Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Tarsus Pharmaceuticals, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on applying proven chemistry to address unmet needs in ophthalmic disease. The company's lead product candidate treats Demodex blepharitis, a disease caused by mite infestation of eyelids. Tarsus is developing novel therapeutic approaches for eye and skin conditions.